首页> 外文期刊>African Journal of Emergency Medicine >Drop for drop: A descriptive analysis of blood product usage in a South African tertiary care setting during the Covid-19 pandemic
【24h】

Drop for drop: A descriptive analysis of blood product usage in a South African tertiary care setting during the Covid-19 pandemic

机译:下降跌落:在Covid-19流行病中南非三级护理环境中血液产品使用的描述性分析

获取原文
           

摘要

BackgroundThe Covid-19 pandemic has had a drastic effect on the global community. Blood products are precious resources especially in the African context and this has been especially compounded during the Covid-19 pandemic. Concurrent to this during the Covid-19 level 5 lockdown in South Africa from 26 March – 30 April 2020, a decrease in trauma admissions to state hospitals was noted. The aim of this data collection was to assess whether lowered blood product issuance was seen during the Covid-19 pandemic lockdown.MethodAreas at Tygerberg Hospital with trauma patients were identified, namely: the A1W intensive care unit (Surgical ICU), Trauma Front Room (Trauma Admissions), Trauma Resuscitation unit (Trauma Resus Area) and J7(Trauma Ward). Data of blood product issuance (red blood cells and fresh frozen plasma) for these 4 areas was provided by the Western Cape Blood Service for the period 26 March-30 April 2018, 2019 and 2020. This included the stage 5 Covid-19 South African lockdown, as well as Easter for all three years which is traditionally associated with raised trauma admissions. This data was quantitative.Results201 products were issued in 2018 versus 103 for the same period in 2020 for the 4 trauma areas in Tygerberg Hospital. The surgical ICU received the most products over 3?years with 183 of the product issuances.DiscussionAs expected there was a significant decrease in blood product (red blood cell and fresh frozen plasma) issuance during the 2020 period which paralleled the lowered trauma numbers. This represented a significant cost saving of over R150 000 despite increased yearly costs for blood products over the same period. This data collection did not consider the reasoning for these blood transfusions or the clinical appropriateness thereof. The author acknowledges the wide variability of transfusion thresholds and protocols within various centres around the world, including Tygerberg and was not seeking to prove commentary on the appropriateness thereof in this research.
机译:背景Covid-19大流行对全球社区产生了剧烈影响。血液制品是珍贵的资源,特别是在非洲背景下,这在Covid-19大流行期间受到特别复杂的。在4月26日至20日4月26日,南非的Covid-19级锁定期间并发在5级锁定期间,注意到对国家医院的创伤录取减少。该数据收集的目的是评估在Covid-19大流行锁定期间是否看到降低的血液产品发布。鉴定了Tygerberg医院的Tygerberg医院,即:A1W重症监护室(手术ICU),创伤前室(创伤录取),创伤复苏单位(创伤归核区)和J7(创伤病房)。这4个地区的血液产品发布(红细胞和新鲜冷冻等离子体)的数据由西开普血服务于2018年4月26日至2019年4月30日,2019年4月30日,这包括第5阶段Covid-19南非所有三年的锁定,传统上与​​募集创伤录取有关的复活节。该数据是量化的。结果2018年产品已在2018年在2018年发布,同期为2020年的同期,在Tygerberg医院的4个创伤区。手术ICU收到超过3多年的产品,183年,产品发行183年.Discussionas预计在2020年期间血液产品(红细胞和新鲜冷冻等离子体)发布的显着降低,并平行于下降的创伤。这表明,尽管在同一时期增加了血液产品的成本,但超过R150 000的显着节省了。该数据收集没有考虑这些输血或其临床适用性的推理。作者承认全球各地各个中心内的输输电阈值和协议的广泛变化,包括Tygerberg,并没有寻求对本研究的适当性进行评论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号